Premium
Immunoelectron microscopy of TDP‐43 in frontotemporal lobar degeneration, amyotrophic lateral sclerosis and Lewy body disease
Author(s) -
Lin WenLang,
Dickson Dennis W
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.58.12
Subject(s) - amyotrophic lateral sclerosis , immunoelectron microscopy , frontotemporal lobar degeneration , lewy body , neurite , neurofilament , immunogold labelling , pathology , soma , chemistry , cytoplasmic inclusion , electron microscope , neuroscience , biology , ultrastructure , frontotemporal dementia , microbiology and biotechnology , cytoplasm , medicine , parkinson's disease , dementia , immunohistochemistry , disease , biochemistry , physics , optics , in vitro
TAR DNA‐binding protein of 43 kDa (TDP‐43) is a nuclear protein involved in transcriptional repression and alternative splicing. It has been shown to be a component of ubiquitin‐positive, tau‐ and á‐synuclein‐negative inclusions in neuronal soma and nuclei as well as neurites of frontotemporal lobar degeneration (FTLD‐U) and in motor neurons of amyotrophic lateral sclerosis (ALS). Recently, it has been co‐localized with Lewy bodies in Lewy body disease (LBD). In this study we use immunogold electron microscopy to study the ultrastructural features of TDP‐43‐labeled structures. The results showed that in all FTLD‐U, ALS and LBD, TDP‐43 was localized to filaments coated with granular material. Both coated and uncoated regions of the filaments were labeled. In FTLD‐U a subset of neurites filled with densely packed filaments were also labeled. The filaments have a diameter of 10–17 nm. Neurofilament and glial filaments were not labeled by TDP‐43. The data suggests that TDP‐43 is a constituent protein in filamentous inclusions in neurodegenerative diseases. Supported by NIH grant AG17216.